A model to estimate the probability of human immunodeficiency virus and hepatitis C infection despite negative nucleic acid testing among increased-risk organ donors

Transplant Infectious Disease

Volumn 19, Issue 2, 2017, Pages

  Annambhotla, Pallavi D ^a,b   Gurbaxani, Brian M ^c,d   Kuehnert, Matthew J ^a   Basavaraju, Sridhar V ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Georgia Institute of Technology   (United States)

Author keywords

hepatitis C virus; human immunodeficiency virus; increased infectious risk; increased risk donor; nucleic acid testing

Indexed keywords

ANAL INTERCOURSE; ARTICLE; DRUG USE; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONTE CARLO METHOD; NUCLEIC ACID ANALYSIS; ORGAN DONOR; PRIORITY JOURNAL; SEX WORKER; SEXUAL BEHAVIOR; UNPROTECTED SEX; VIROGENESIS; VIRUS LOAD; VIRUS TRANSMISSION; ALLOGRAFT; BLOODBORNE BACTERIUM; DISEASE TRANSMISSION; DONOR; HEPACIVIRUS; HIGH RISK BEHAVIOR; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; ISOLATION AND PURIFICATION; NUCLEIC ACID AMPLIFICATION; PRACTICE GUIDELINE; PROSTITUTION; PSYCHOLOGY; RISK; SEROLOGY; STANDARDS; STATISTICS AND NUMERICAL DATA; THEORETICAL MODEL; TIME FACTOR; TRANSPLANTATION; VIROLOGY;

VIRUS RNA;

ALLOGRAFTS; BLOOD-BORNE PATHOGENS; DISEASE TRANSMISSION, INFECTIOUS; HEPACIVIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; MODELS, THEORETICAL; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PRACTICE GUIDELINES AS TOPIC; RISK; RISK-TAKING; RNA, VIRAL; SEROLOGIC TESTS; SEX WORK; TIME FACTORS; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; VIRAL LOAD;

EID: 85017010181     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12676     Document Type: Article

References (32)

1. Centers for Disease Control and Prevention (CDC). Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. MMWR Morbid Mortal Weekly Rep. 1994;43(RR-8):1-17.
2. Seem DL, Lee I, Umscheid CA, Kuehnert MJ. PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation. Public Health Rep. 2013;128:247-343.
3. CDC. Human immunodeficiency virus infection transmitted from an organ donor screened for HIV antibody–North Carolina. MMWR Morbid Mortal Weekly Rep. 1987;36:306-308.
4. CDC. HIV transmitted from a living organ donor–New York City, 2009. MMWR Morbid Mortal Weekly Rep. 2011;60:297-301.
5. Boelen L, Teutsch S, Wilson DP, et al., on behalf of the HITS investigators. Per-event probability of hepatitis C infection during sharing of injecting equipment. PLoS One. 2014;9:1-8.
6. Pouget ER, Hagan H, Des Jarlais DC. Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction. 2012;107:1057-1065.
7. Hahn JA, Page-Shafer K, Lum PJ, et al. Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. J Infect Dis. 2002;186:1558-1564.
8. Hagan H, Pouget ER, Williams IT, et al. Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 cities. J Infect Dis. 2010;201:378-385.
9. Hagan H, Thiede H, Des Jarlais DC. Hepatitis C virus infection among injection drug users. Epidemiology. 2004;15:543-549.
10. Ison MG, Stosor V. Transplantation of high-risk donor organs: A survey of US solid organ transplant center practices as reported by transplant infectious diseases physicians. Clin Transplant. 2009;23:866-873.
11. Ros RL, Kucirka LM, Govindan P, Sarathy H, Montgomery RA, Segev DL. Patient attitudes toward CDC high infectious risk donor kidney transplantation: Inferences from focus groups. Clin Transplant. 2012;26:247-253.
12. Sahulee R, Lytrivi ID, Savla JJ, Rossano JW. Centers for Disease Control “high-risk” donor status does not significantly affect recipient outcome after heart transplantation in children. J Heart Lung Transplant. 2014;33:1173-1177.
13. Hudgens MG, Longini IM Jr, Vanichseni S, et al. Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok. Thailand. 2002;155:159-168.
14. Kaplan EH, Heimer R. A model-based estimate of HIV infectivity via needle sharing. J Acq Immun Defic Synd. 1992;5:1116-1118.
15. Kimani J, Kaul R, Nagelkerke NJ, et al. Reduced rates of HIV acquisition during unprotected sex by Kenyan female sex workers predating population declines in HIV prevalence. AIDS. 2008;22:131-137.
16. Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk: A systematic review. AIDS. 2014;28:1509-1519.
17. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis. 2005;191:1403-1409.
18. Hughes JP, Baeten JM, Lingappa JR, et al. Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis. 2012;205:358-365.
19. Jin F, Jansson J, Law M, et al. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS. 2010;24:907-913.
20. Xu F, Sternberg MR, Markowitz LE. Men who have sex with men in the United States: Demographic and behavioral characteristics and prevalence of HIV and HSV-2 infection: Results from National Health and Nutrition Examination Survey 2001-2006. Sex Transm Dis. 2010;37:399-405.
21. Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol. 1999;150:306-311.
22. Weusten JJ, van Drimmelen HA, Lelie PN. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT. Transfusion. 2002;42:537-548.
23. Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM. Relation between HIV viral load and infectiousness: A model-based analysis. Lancet. 2008;372:314-320.
24. Pilcher CD, Tien HC, Eron JJ Jr, et al. Brief but efficient: Acute HIV infection and the sexual transmission of HIV. J Infect Dis. 2004;189:1785-1792.
25. Parker RA, Regan MM, Reimann KA. Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus: Implications for using nonhuman primate AIDS models to test vaccines and therapeutics. J Virol. 2001;75:11234-11238.
26. Johnson NL. Systems of frequency curves generated by methods of translation. Biometrika. 1949;36(Pt 1–2):149-176.
27. Querec TD, Gurbaxani BM, Unger ER. Randomization modeling to ascertain clustering patterns of human papillomavirus types detected in cervicovaginal samples in the United States. PLoS One. 2013;8:e82761.
28. Kucirka LM, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL. Provider utilization of high-risk donor organs and nucleic acid testing: Results of two national surveys. Am J Transplant. 2009;9:1197-1204.
29. Reese PP, Feldman HI, Asch DA, et al. Transplantation of kidneys from donors at increased risk for blood-borne viral infection: Recipient outcomes and patterns of organ use. Am J Transplant. 2009;9:2338-2345.
30. CDC. Prevalence and awareness of HIV infection among men who have sex with men–21 cities, United States, 2008. MMWR Morbid Mortal Weekly Rep. 2010;59:1201-1207.
31. Hall HI, An Q, Tang T, et al. Prevalence of diagnosed and undiagnosed HIV infection-United States, 2008–2012. MMWR Morbid Mortal Weekly Rep. 2015;64:657-662.
32. Lansky A, Finlayson T, Johnson C, et al. Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and hepatitis C virus infections. PLoS One. 2014;9:e97596.